Browsing by Author "Cuenca Royo, Aida Ma, 1981-"

Sort by: Order: Results:

  • Sola Llopis, Susana de; Torre Fornell, Rafael de la; Sánchez Benavides, Gonzalo; Benejam, Bessy; Cuenca Royo, Aida Ma, 1981-; Del Hoyo Soriano, Laura; Rodríguez, Joan; Catuara Solarz, Silvina, 1986-; Sánchez Gutiérrez, Judit; Dueñas-Espín, Iván, 1979-; Hernández, Gimena; Peña-Casanova, J. (Jordi); Langohr, Klaus; Videla, Sebastià; Blehaut, Henry; Farré Albaladejo, Magí; Dierssen, Mara; TESDAD Study Group (Frontiers, 2015)
    The recent prospect of pharmaceutical interventions for cognitive impairment of Down syndrome (DS) has boosted a number of clinical trials in this population. However, running the trials has raised some methodological ...
  • Torre Fornell, Rafael de la; De Sola Llopis, Susana; Xicota Vila, Laura, 1987-; Cuenca Royo, Aida Ma, 1981-; Rodriguez, Joan; Gomis González, Maria; Hernández, Gimena; Del Hoyo Soriano, Laura; Ozaita Mintegui, Andrés, 1969-; Dierssen, Mara; TESXF Study Group; Principe, Alessandro; Espadaler, Josep María; Roca, Laia; Del Hoyo Soriano, Laura; Farré Albaladejo, Magí; Fitó Colomer, Montserrat; León Jorba, Alba; Banea, Ovideo; Maldonado, Rafael, 1961-; Busquets Garcia, Arnau, 1985- (Elsevier, 2019)
    Background & aims: Despite the wide spectrum of experimental compounds tested in clinical trials, there is still no proven pharmacological treatment available for Fragile-X syndrome (FXS), since several targeted clinical ...
  • Cuenca Royo, Aida Ma, 1981- (Universitat Pompeu Fabra, 2014-01-22)
    El cannabis es la droga ilegal de uso más extendido en España siendo la prevalencia de su consumo elevada (17% en el último año-población de 15 a 34 años). Dado que diversos estudios muestran que sólo una pequeña proporción ...
  • Galindo Guarín, Liliana; Moreno, Estefanía; López-Armenta, Fernando; Guinart, Dani; Cuenca Royo, Aida Ma, 1981-; Izquierdo Serra, Mercè; Xicota Vila, Laura, 1987-; Fernandez, Cristina; Menoyo Colomer, Esther; Fernández-Fernández, José Manuel; Benítez-King, Gloria; Canela, Enric I.; Casadó, Vicent; Pérez Solá, Victor; Torre Fornell, Rafael de la; Robledo, Patricia, 1958- (Springer, 2018)
    Cannabinoid CB1 receptors (CB1R) and serotonergic 2A receptors (5HT2AR) form heteromers in the brain of mice where they mediate the cognitive deficits produced by delta-9-tetrahydrocannabinol. However, it is still unknown ...
  • Cuyàs, Elisabet; Verdejo García, Antonio; Fagundo, Ana B.; Khymenets, Olha, 1974-; Rodríguez, Joan; Cuenca Royo, Aida Ma, 1981-; De Sola Llopis, Susana; Langohr, Klaus; Peña-Casanova, J. (Jordi); Torrens, Marta; Martín Santos, Rocío; Farré Albaladejo, Magí; Torre Fornell, Rafael de la (Public Library of Science (PLoS), 2011)
    This study is aimed to clarify the association between MDMA cumulative use and cognitive dysfunction, and the potential role of candidate genetic polymorphisms in explaining individual differences in the cognitive effects ...
  • Del Hoyo Soriano, Laura; Xicota Vila, Laura, 1987-; Sánchez Benavides, Gonzalo; Cuenca Royo, Aida Ma, 1981-; Sola Llopis, Susana de; Langohr, Klaus; Fagundo, Ana B.; Farré Albaladejo, Magí; Dierssen, Mara; Torre Fornell, Rafael de la (Frontiers, 2015)
    Down syndrome (DS) is an intellectual disability (ID) disorder in which language and specifically, verbal fluency are strongly impaired domains; nearly all adults show neuropathology of Alzheimer's disease (AD), including ...
  • Mallorquí-Bagué, Nuria; Cuenca Royo, Aida Ma, 1981-; Castañer, Olga; Torre Fornell, Rafael de la; Fernández Aranda, Fernando (Nature Research, 2018)
    This study cross-sectionally examines in the elderly population: (a) the association of type 2 diabetes with executive function (EF); (b) the effect of BMI on both type 2 diabetes and EF; (c) the association between glycaemia ...
  • Del Hoyo Soriano, Laura; Xicota Vila, Laura, 1987-; Langohr, Klaus; Sánchez Benavides, Gonzalo; Sola Llopis, Susana de; Cuenca Royo, Aida Ma, 1981-; Rodríguez, Joan; Rodríguez-Morató, Jose, 1987-; Farré Albaladejo, Magí; Dierssen, Mara; Torre Fornell, Rafael de la; The TESDAD Study Group (Frontiers, 2016)
    Down syndrome (DS) is an aneuploidy syndrome that is caused by trisomy for human chromosome 21 resulting in a characteristic cognitive and behavioral phenotype, which includes executive functioning and adaptive behavior ...